Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
about
Venetoclax is effective in small cell lung cancers with high BCL-2 expression.Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction.ΔNp63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.Usnic Acid Induces Cycle Arrest, Apoptosis, and Autophagy in Gastric Cancer Cells In Vitro and In Vivo.Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies.Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.Bax retrotranslocation potentiates Bcl-xL's antiapoptotic activity and is essential for switch-like transitions between MOMP competency and resistance.BH3-Dependent and Independent Activation of BAX and BAK in Mitochondrial ApoptosisBCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
P2860
Q45072361-C9E9E088-F99B-460B-A5C4-716716CF8AC6Q47107276-D9BBC873-F434-45C3-B28C-B1935FCD67EDQ47323308-E053261C-4072-4EFF-8E38-28CCE103EE91Q49510133-6717C872-B37E-461F-8418-F7344E4F38ECQ50097295-642E93DA-4849-4F58-9661-8E0FFC0EBDC8Q53701820-BC43DB5E-7B49-4613-81E7-7318EC0B3BB1Q54989154-A32DF3AB-6654-443A-997C-1E09B3B49A07Q58573059-D85BEDB9-C2F3-48E2-9AC5-38333775987EQ58779838-8E5CF5E9-5983-42CF-9368-CE4E6CEA04E0
P2860
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
@en
type
label
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
@en
prefLabel
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
@en
P2093
P2860
P356
P1476
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
@en
P2093
Akane Inoue-Yamauchi
Emily H Cheng
Hui-Chen Chen
Kota Ishizawa
Kwanghee Kim
Maria C Pietanza
Mark G Kris
Matthew D Hellmann
Paul S Jeng
P2860
P2888
P356
10.1038/NCOMMS16078
P407
P577
2017-07-17T00:00:00Z
P6179
1090739674